Zentalis Pharmaceuticals, Inc. (ZNTL)

Market Closed

1 Sep, 20:00

NASDAQ (NMS)

$

3. 71

-0.05

-1.3298%

267.66M Market Cap

- P/E Ratio

- Div Yield

862,997 Volume

-3.66 Eps

$ 3.76

Previous Close

Investors:

Add Transaction

Day Range

3.55 3.73

Year Range

1.21 6.95

Want to track ZNTL and more in your Portfolio? 🎯

Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Get Started For Free

Zentalis Pharmaceuticals, Inc. Investors

Name	Quantity	Cost	Value	Profit ($)	Gain (%)
Madelyn D. Purcell Pfizer Inc	953,834	$2.89M	$4.09M	$1.2M	41.58%
BZ Brandon Zatopek Commonwealth Equity Services LLC	61,412	$297,850	$259,158.64	-$38,691.36	-12.99%
BG Bart Gancher Intech Investment Management LLC	10,460	$50,731	$43,409	-$7,322	-14.43%
Joseph Castro Nuveen LLC	66,674	$323,369	$276,697.1	-$46,671.9	-14.43%
Lindsey Seagraves Carson Advisory Inc.	21,170	$85,994.2	$87,855.5	$1,861.3	2.16%
Drew Phillips Fortitude Family Office LLC	209	$489	$990.66	$501.66	102.59%
Hui Fai Tam Caitong International Asset Management Co. Ltd.	31	$150	$146.94	-$3.06	-2.04%
Corey Saft Sivia Capital Partners, LLC	20,000	$27,000	$94,800	$67,800	251.11%
Mark Schafer Police & Firemen's Retirement System of New Jersey	14,755	$71,562	$69,938.7	-$1,623.3	-2.27%
PLC Peapod Lane Capital LLC Peapod Lane Capital LLC	202,864	$321,721.3	$961,575.36	$639,854.06	198.88%
JCB John Ciaran Burns Universal-Beteiligungs- und Servicegesellschaft mbH	10,096	$16,052.64	$47,855.04	$31,802.4	198.11%

1

Blog Affiliate Program About Terms Privacy Help Contact Us

2026 © Marketlog. All Rights Reserved.